[go: up one dir, main page]

DK343581A - Fremgangsmaade til fremstilling af et triamterenpraeparat - Google Patents

Fremgangsmaade til fremstilling af et triamterenpraeparat

Info

Publication number
DK343581A
DK343581A DK343581A DK343581A DK343581A DK 343581 A DK343581 A DK 343581A DK 343581 A DK343581 A DK 343581A DK 343581 A DK343581 A DK 343581A DK 343581 A DK343581 A DK 343581A
Authority
DK
Denmark
Prior art keywords
preparation
triangle
procedure
triangle preparation
Prior art date
Application number
DK343581A
Other languages
English (en)
Inventor
M Horlington
V Scott
Original Assignee
Smith & Nephew
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith & Nephew filed Critical Smith & Nephew
Publication of DK343581A publication Critical patent/DK343581A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK343581A 1980-08-01 1981-07-31 Fremgangsmaade til fremstilling af et triamterenpraeparat DK343581A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8025286 1980-08-01
GB8100521 1981-01-08
GB8110448 1981-04-02

Publications (1)

Publication Number Publication Date
DK343581A true DK343581A (da) 1982-02-02

Family

ID=27260977

Family Applications (1)

Application Number Title Priority Date Filing Date
DK343581A DK343581A (da) 1980-08-01 1981-07-31 Fremgangsmaade til fremstilling af et triamterenpraeparat

Country Status (7)

Country Link
US (2) US4425344A (da)
EP (1) EP0045617A3 (da)
CA (1) CA1163560A (da)
DK (1) DK343581A (da)
GB (1) GB2082455B (da)
IE (1) IE51421B1 (da)
NZ (1) NZ197814A (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3448490C2 (de) * 1984-04-05 1995-04-27 Roehm Pharma Gmbh Verwendung von Pteridinderivaten zur Behandlung von Herzarrhythmien
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
FR2608045B1 (fr) * 1986-12-12 1990-03-02 Chauvin Laboratoires Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome
US5500230A (en) * 1987-01-23 1996-03-19 The General Hospital Corporation Method for treatment of glaucoma with nitrogen containing guanylate cyclase activators
ATE66147T1 (de) * 1987-02-13 1991-08-15 Allergan Pharma Verwendung von pteridinen und/oder purinen oder eines xanthinoxidase-hemmers zur herstellung eines arzneimittels zur behandlung von genetisch bedingten degenerativen netzhauterkrankungen.
US4793999A (en) * 1987-03-27 1988-12-27 Sheth Prabhakar R Method of manufacturing an antihypertensive, diuretic and antihypokalemic pharmaceutical composition with polyethylene glycol
US4981852A (en) * 1988-05-13 1991-01-01 Multilan Ag Chemical compounds triamterene and hydrochlorothiazide
JPH0311016A (ja) * 1989-06-09 1991-01-18 Tokyo Tanabe Co Ltd ピリド［１，２―ａ］ピリミジン誘導体の水性製剤
CA2136321A1 (en) * 1992-05-22 1993-12-09 Takahiro Ogawa Pharmaceutical composition for use in glaucoma treatment
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
MXPA01012223A (es) * 1999-05-28 2002-07-02 Novartis Ag Paquete para un producto farmaceutico y metodo para esterilizar el paquete.
TWI227143B (en) 1999-12-15 2005-02-01 Guo-Jiun Sung In situ gel formation for ophthalmic delivery by combining Pluronic/Carbopol medic composition and its preparing method
US7614993B2 (en) * 2001-07-20 2009-11-10 Dixie Consumer Products Llc Liquid container with uninterrupted comfort band and method of forming same
DE10158488A1 (de) * 2001-11-28 2003-06-12 Wolff Cellulosics Gmbh & Co Kg Lösungsverzögerte Celluloseether und ein Verfahren zu ihrer Herstellung
US20040034042A1 (en) * 2002-08-14 2004-02-19 Masao Tsuji Preservative composition
US7022740B2 (en) * 2004-04-29 2006-04-04 Leonard Mackles Lubricious ophthalmic solutions
US20070173538A1 (en) * 2005-12-23 2007-07-26 Alcon, Inc. PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
MX2009012879A (es) * 2007-07-20 2010-01-14 Alcon Inc Formulacion farmaceutica para suministrar a los ojos compuestos que inhiben el receptor tirosina cinasa (rtki).
US8273725B2 (en) * 2009-09-10 2012-09-25 Genzyme Corporation Stable hyaluronan/steroid formulation
US20120225918A1 (en) * 2011-03-03 2012-09-06 Voom, Llc Compositions and Methods for Non-Surgical Treatment of Ptosis
MA50991B1 (fr) * 2017-12-04 2023-03-31 Salvat Lab Sa Composition topique ophtalmique comprenent de l'acide dobesilique pour le traitement des maladies du segment postérieur de l' il
US20210060017A1 (en) * 2018-02-27 2021-03-04 Shilpa Medicare Ltd Methotrexate ophthalmic solution
US10799481B1 (en) 2019-05-06 2020-10-13 Rvl Pharmaceuticals, Inc. Compositions and methods for treating ocular disorders
US20240261291A1 (en) * 2021-06-11 2024-08-08 Brien Holden Vision Institute Limited Ophthalmic Compositions and/or Methods for Presbyopia, Mydriasis and/or Ocular Discomfort Management

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB932256A (en) 1959-05-04 1963-07-24 Smith Kline French Lab Diuretic compositions
US3081230A (en) 1960-09-08 1963-03-12 Smith Kline French Lab Diuretic and antihypertensive triaminoarylpteridines
US3870791A (en) 1972-04-24 1975-03-11 Heskel M Haddad Solid state ophthalmic medication delivery method
US4187307A (en) 1978-10-16 1980-02-05 Abbott Laboratories Diuretics
US4285947A (en) 1980-01-18 1981-08-25 Interx Research Corporation Aldehyde adducts of triamterene

Also Published As

Publication number Publication date
GB2082455A (en) 1982-03-10
EP0045617A2 (en) 1982-02-10
CA1163560A (en) 1984-03-13
EP0045617A3 (en) 1982-12-22
IE51421B1 (en) 1986-12-24
NZ197814A (en) 1984-07-31
US4425345A (en) 1984-01-10
GB2082455B (en) 1984-06-06
US4425344A (en) 1984-01-10
IE811654L (en) 1982-02-01

Similar Documents

Publication Publication Date Title
DK195083A (da) Fremgangsmaade til fremstilling af et glaucomapraeparat
DK343581A (da) Fremgangsmaade til fremstilling af et triamterenpraeparat
DK161179C (da) Fremgangsmaade til formgivning af et nydelsesmiddel
DK161581A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK150903C (da) Analogifremgangsmaade til fremstilling af benzisoselenazoloner
DK522081A (da) Fremgangsmaade til fremstilling af xanthater
DK100281A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK1584D0 (da) Fremgangsmade til fremstilling af et gitterkernesandwichelement
DK465581A (da) Fremgangsmaade til fremstilling af tetrasubstituerede benzenderivater
DK172181A (da) Fremgangsmaade til fremstilling af 9-carbamoyl-9-aminoalkylfluoren-derivater
DK364481A (da) Fremgangsmaade til fremstilling af caprylolactamer
DK46781A (da) Fremgangsmaade til fremstilling af antirhinovirusmidler
DK296281A (da) Fremgangsmaade til fremstilling af aminocyklopentanonamider
DK579181A (da) Fremgangsmaade til fremstilling af diarylthiophener
DK471181A (da) Fremgangsmaade til fremstilling af et pyrimidinderivat
DK206582A (da) Fremgangsmaade til fremstilling af et furanderivat
DK153841C (da) Fremgangsmaade til fremstilling af ranitidin
DK12581A (da) Fremgangsmaade til fremstilling af kijanimicin
DK126181A (da) Fremgangsmaade til fremstilling af bicyclooctanforbindelser
DK62181A (da) Praeparat til fjernelse af maling
DK21281A (da) Fremgansmaade til fremstilling af triazolderivater
DK7181A (da) Fremgangsmaade til fremstilling af et furanderivat
DK417881A (da) Fremgangsmaade til fremstilling af et fortykkelsesmiddel
DK89280A (da) Fremgangsmaade til fremstilling af et carbazolderivat
DK457680A (da) Fremgangsmaade til fremstilling af et urinstofderivat

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment